• Contact Us
PAVmed Inc. - Innovating at the speed of life. PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact
PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • NASDAQ: PAVM
    • NASDAQ: PAVMZ
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022

Aug 01, 2022 8:25am EDT

PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America

Jul 19, 2022 8:25am EDT

Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference

Jul 18, 2022 8:25am EDT

PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO

May 13, 2022 8:25am EDT

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

May 12, 2022 4:38pm EDT

Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

May 11, 2022 4:00pm EDT

Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans

May 09, 2022 8:25am EDT

PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit

Apr 28, 2022 4:05pm EDT

PAVmed to Hold a Business Update Conference Call on May 12, 2022

Apr 26, 2022 8:25am EDT

Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022

Apr 25, 2022 8:25am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...23
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    About PAVmed Inc.

    PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

    Follow Us

    PAVmed Inc

    One Grand Central Place, Suite 4600
    New York, NY 10165
    212-949-4319
    info@pavmed.com


    PAVmed Inc. - Innovating at the speed of life.
    © Copyright 2023. All Rights Reserved by PAVmed Inc. .
    • News
    • Contact
    • Privacy Policy
    For more information regarding the proposed terms of settlement of a pending class action lawsuit, please click here.